Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy

BACKGROUND: Polypharmacy is ubiquitous in patients on hemodialysis (HD), and increases risk of adverse events, medication interactions, nonadherence, and mortality. Appropriately applied deprescribing can potentially minimize polypharmacy risks. Existing guidelines are unsuitable for nephrology clin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Can J Kidney Health Dis
Autori principali: Lefebvre, Melissa J., Ng, Patrick C. K., Desjarlais, Arlene, McCann, Dennis, Waldvogel, Blair, Tonelli, Marcello, Garg, Amit X., Wilson, Jo-Anne, Beaulieu, Monica, Marin, Judith, Orsulak, Cali, Lloyd, Anita, McIntyre, Caitlin, Feldberg, Jordanne, Bohm, Clara, Battistella, Marisa
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2020
Soggetti:
Original Clinical Research Quantitative
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7605037/
https://ncbi.nlm.nih.gov/pubmed/33194213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2054358120968674
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi